Visit-to-visit systolic blood pressure variability in patients with ST-elevation myocardial infarction predicts long-term cardiovascular outcomes
| Autor: | So-Yeon Choi, Jin-Sun Park, Byoung-Joo Choi, Myeong-Ho Yoon, Seung-Jea Tahk, Joon-Han Shin, Moon-Seung Soh, Hong-Seok Lim, Hyoung-Mo Yang, Kyoung-Woo Seo, Gyo-Seung Hwang |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Male
medicine.medical_specialty Time Factors viruses Blood Pressure Review Article 030204 cardiovascular system & hematology Risk Assessment 03 medical and health sciences Percutaneous Coronary Intervention Clinical trials 0302 clinical medicine Recurrence Risk Factors Cause of Death Internal medicine Internal Medicine medicine Humans cardiovascular diseases 030212 general & internal medicine Myocardial infarction Progression-free survival Aged Retrospective Studies Cause of death Preventive medicine business.industry Retrospective cohort study Middle Aged biochemical phenomena metabolism and nutrition Prognosis medicine.disease Progression-Free Survival Confidence interval Blood pressure Hypertension Cardiology ST Elevation Myocardial Infarction Female Risk assessment business Mace |
| Zdroj: | Journal of Human Hypertension |
| ISSN: | 1476-5527 0950-9240 |
| DOI: | 10.1038/s41371-019-0176-0 |
| Popis: | Elevated visit-to-visit blood pressure variability (BPV), independent of mean BP, has been associated with cardiovascular events. However, its impact after ST-elevation myocardial infarction (STEMI) has not been established. This study aimed to investigate the prognostic impact of BPV on patients after STEMI. We analyzed the data and clinical outcomes of STEMI survivors who underwent successful primary coronary intervention from 2003 to 2009. BP was measured at discharge and at 1, 3, 6, 12, 24, and 36 months, and we calculated BPV as the intra-individual standard deviations (SDs) of systolic BP (SBP) across these measurements. We classified the patients as high and low-BPV group, and evaluated the outcomes: occurrence of major adverse cardiovascular events (MACEs), death, recurrent myocardial infarction, and target vessel revascularization within 60 months. We enrolled 343 patients, and mean follow-up duration was 68 ± 34 months (median: 76 months). Mean and median SBP SDs were 13.2 and 12.3 mmHg, and patients were divided into one of the two groups based on the median (high-BPV group = SD ≥ 12.3 mmHg; low-BPV group = SD |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink